Signifor LAR (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Signifor LAR drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | pasireotide |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-12-15 |
END MARKETING DATE: | 0000-00-00 |
Signifor LAR HUMAN PRESCRIPTION DRUG Details:
Item Description | Signifor LAR from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2014-12-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0641_ee1e0de3-3f24-4d65-937a-2955a90ea9ab |
PRODUCT NDC: | 0078-0641 |
APPLICATION NUMBER: | NDA203255 |